Neil William Aubuchon, Chief Commercial Officer at Viking Therapeutics ($VKTX), made one open market purchase of shares in the last year, totaling about $150,000. His latest buy occurred on March 10, 2026. Among 4,983 insiders, his activity ranks 1,823rd by purchase value, well below the average of $1.46 million over 3.3 transactions per insider. Aubuchon reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Viking Therapeutics, Inc. | $VKTX | Aubuchon Neil William | Chief Commercial Officer | P | Common Stock, par value $0.00001 per share | 4475 | $33.50 | 4,475.0000 | 115,554,295 | 9999.99% | 0.00% |
| Jan. 12, 2026 | Viking Therapeutics, Inc. | $VKTX | Aubuchon Neil William | Chief Commercial Officer | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 113,036,344 | 9999.99% | 0.16% |